71,951 research outputs found
Fernandez, C.
Centro Asturiano membership record of C. Fernandez; Socio Number: 84939.https://digitalcommons.usf.edu/asturiano_membership/2591/thumbnail.jp
Fernandez, Amparo C.
Centro Asturiano membership record of Amparo C. Fernandez; Socio Number: 122.https://digitalcommons.usf.edu/asturiano_membership/2681/thumbnail.jp
Correction to: Eye Movement Desensitization and Reprocessing in Child and Adolescent Psychology: a Narrative Review (Current Treatment Options in Psychiatry, (2021), 8, 3, (95-109), 10.1007/s40501-021-00244-0)
The original publication of this article contained mistakes and the author would like to correct them. There is an error in the affiliation of author Isabel Fernandez. Isabel Fernandez is not affiliated to Catholic University. She is only affiliated to “Centro di Ricerca e Studi in Psicotraumatologia (C.R.S.P.), Milan, Italy.” The original article has been corrected
Figure 2 from: Fernandez-Hilario R, Arteaga R (2017) A new species of Raputia (Rutaceae) from the Selva Central of Peru. PhytoKeys 89: 73-84. https://doi.org/10.3897/phytokeys.89.20136
Figure 2 -
Raputia codo-pozuzoensis. A Habit B Inflorescence (R. Fernandez & R. Arteaga 1079; MOL) C, D Flowers (R. Fernandez et al. 830; MOL). Photos by Robin Fernandez
Marriage record of Fernandez, Jose C. and Garcia, Otilia
Marriage license for Jose C. Fernandez and Otilia Garcia. B.L. Gonzalez was the Notary Public
Joint effects of family history and adult life dietary risk factors on colorectal cancer risk
Background. We analyzed the joint effects of family history of colorectal cancer and adult life dietary risk factors on colorectal cancer risk. Methods. We used data from a case-control study conducted in northern Italy between 1985 and 1992, including 1584 cases with colorectal cancer and 2879 controls. We created an adult life dietary risk factor score. Results. Among subjects with family history of colorectal cancer, those in the lowest risk score tertile were not at elevated risk of colorectal cancer (odds ratio = 1.2; 95% confidence interval = 0.7-2.1), whereas those in the highest score tertile were at increased risk (odds ratio = 5.5; 95% confidence interval = 3.5-8.7). Conclusions. These findings indicate that the expression of familial susceptibility can be substantially modified by adult life risk factors. RI Fernandez, Esteve/A-9750-200
Corrigendum to “The 2016 update of the International Study Group (ISGPF) definition and grading of postoperative pancreatic fistula: eleven years after.” Surgery 2017. Mar; 161 (3):584–591. Epub Dec 28, 2016 (Surgery (2017) 161(3) (584–591), (S0039606016307577), (10.1016/j.surg.2016.11.014))
The authors regret that the name of author Charles R. Vollmer MD is incorrect in the final published version. The correct name Charles Vollmer. The authors would like to apologise for any inconvenience caused. Below is the correct order of authors: Claudio Bassi, MDa, Giovanni Marchegiani, MDa, Christos Dervenis, MD,b, Micheal Sarr, MDc, Mohammad Abu Hilal, MDd, Mustapha Adham, MDe, Peter Allen, MDf, Roland Andersson, MDg, Horacio J. Asbun, MDh, Marc G. Besselink, MDi, Kevin Conlon, MDj, Marco Del Chiaro, MDk, Massimo Falconi, MDl, Laureano Fernandez-Cruz, MDm, Carlos Fernandez-del Castillo, MDn, Abe Fingerhut, MDo, Helmut Friess, MDp, Dirk J Gouma, MDi, Thilo Hackert, MDq, Jakob Izbicki, MDr, Keith D. Lillemoe, MDn, John P. Neoptolemos, MDs, Attila Olah, MDt, Richard Schulick, MDu, Shailesh V. Shrikhande, MDv, Tadahiro Takada, MDw, Kyoichi Takaori, MDx, William Traverso, MDy, Charles Vollmer, MDz, Christopher L. Wolfgang, MDaa, Charles J. Yeo, MDbb, Roberto Salvia, MDa, Marcus Buchler, MDq, from the International Study Group on Pancreatic Surgery (ISGPS
Trends in lung cancer among young-European women: The rising epidemic in France and Spain
Lung cancer mortality in young women in the European Union (EU) has steadily increased until the mid 1990s and has levelled off thereafter, but trends have been heterogeneous in various countries. We analyzed therefore age-standardized trends in lung cancer mortality in young women (20-44) for the 6 major European countries, using joinpoint regression. In the early 1970s the highest lung cancer mortality in young women was in the UK (2.1/100,000). UK rates, however, steadily declined and in 2000-2004 they were the lowest of all 6 major EU countries (1.2/100,000). The second lowest rate in 2000-2002 was in Italy, whose rates remained around 1.1/100,000 between 1970 and 1994, and increased to 1.4 thereafter. In Germany and Poland, lung cancer rates in young women rose from 0.8-1.0/100,000 in the early 1970s to 1.7-1.9 in the mid 1990s and levelled off during the last decade. Major rises over recent years were observed in France (from 0.8/100,000 in 1985-1989 to 2.2 in 2000-2003) and in Spain (from 0.8 in the 1985-1989 to 1.7 in 2000-2004). Thus, France showed both the highest rate observed over the last 3 decades and the largest rise over the last 2 decades. Since recent trends in the young give relevant information to the likely future trends in middle age, the female lung cancer epidemic is likely to expand in southern Europe from the current rates of 5.0/100,000 in Spain and 7.7 in France to approach 20/100,000 within the next 2-3 decades. Urgent interventions for smoking cessation in women are therefore required. (C) 2007 Wiley-Liss, Inc. RI Fernandez, Esteve/A-9750-200
Sandra C. Fernandez : Under-garments
"For this installation, Fernandez expands from the intricately rendered and intimate boxes and collages of her earlier work into large, over sized skirts that not only engage but enfold the viewer. Previously one opened and inspected her soft sculptures, now one physically enters into their domain, enveloped by their presence." -- Manya Fabiniak, page 1
Hormone replacement therapy and cancer risk: A systematic analysis from a network of case-control studies
To provide comprehensive and quantitative information on the benefits and risks of hormone replacement therapy (HRT) on several cancer sites, we systematically examined the relation between HRT use and the risk of various cancers in women aged 45-79 by using data from a framework of case-control studies conducted in Italy between 1983 and 1999. The overall data set included the following incident, histologically confirmed neoplasms: oral cavity, pharynx, larynx and esophagus (n = 253), stomach (n = 258), colon (n = 886), rectum (n = 488), liver (n = 105), gallbladder (n = 3 1), pancreas (n = 122), breast (n = 4,713), endometrium (n = 704), ovary (n = 1,614), urinary bladder (n = 106), kidney (n = 102), thyroid (n = 65), Hodgkin's disease (n = 26), non-Hodgkin's lymphomas (n = 145), multiple myeloma (n = 65) and sarcomas (n = 78). The control group comprised 6,976 women aged 45-79 years, admitted for a wide spectrum of acute, nonneoplastic conditions. Odds ratios (OR) and the corresponding 95% confidence intervals (CI) for use of HRT were derived from multiple logistic regression equations. There was an inverse association between ever use of HRT and colon (OR = 0.7), rectum (OR = 0.5) and liver cancer (OR = 0.2), with a consistent pattern of protection for duration of use. An excess risk was found for gallbladder (OR = 3.2), breast (OR = 1.1), endometrial (OR = 3.0) and urinary bladder cancer (OR = 2.0). These data from a southern European population add some useful information on the risk-benefit assessment of HRT among postmenopausal women. (C) 2003 Wiley-Liss, Inc. RI Fernandez, Esteve/A-9750-200
- …
